日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation

清髓性异基因造血细胞移植后使用环孢素和霉酚酸酯治疗效果较差

Betty K Hamilton, Ying Liu, Michael T Hemmer, Navneet Majhail, Olle Ringden, Dennis Kim, Luciano Costa, Robert Stuart, Amin Alousi, Joseph A Pidala, Daniel R Couriel, Mahmoud Aljurf, Joseph H Antin, Christopher Bredeson, Jean-Yves Cahn, Mitchell Cairo, Sung Won Choi, Christopher Dandoy, Robert Peter

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure

复发或初次诱导失败的急性白血病的造血干细胞移植治疗

Michel Duval, John P Klein, Wensheng He, Jean-Yves Cahn, Mitchell Cairo, Bruce M Camitta, Rammurti Kamble, Edward Copelan, Marcos de Lima, Vikas Gupta, Armand Keating, Hillard M Lazarus, Mark R Litzow, David I Marks, Richard T Maziarz, David A Rizzieri, Gary Schiller, Kirk R Schultz, Martin S Tallma

Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation

对于接受同种异体外周血干细胞移植的 B 细胞淋巴瘤患者而言,先前使用利妥昔单抗与急性移植物抗宿主病发生率降低和生存率提高相关

Voravit Ratanatharathorn, Brent Logan, Dan Wang, Mary Horowitz, Joseph P Uberti, Olle Ringden, Robert Peter Gale, Hanna Khoury, Mukta Arora, Stephen Spellman, Corey Cutler, Joseph Antin, Martin Bornhaüser, Gregory Hale, Leo Verdonck, Mitchell Cairo, Vikas Gupta, Steven Pavletic; Center for Internati